Experimental VX2 Rabbit Liver Tumor Model in Carbon Tetrachloride-Induced Cirrhosis of the Liver

J Vasc Interv Radiol. 2023 Mar;34(3):404-408.e1. doi: 10.1016/j.jvir.2022.11.026. Epub 2022 Dec 5.

Abstract

Liver cirrhosis is a major underlying factor in the development of hepatocellular carcinoma. Currently, there is an unmet need for midsize experimental vertebrate models that would offer reproducible implantable liver tumors in a cirrhotic liver background. This study establishes a protocol for a syngeneic rabbit model of VX2 liver cancer with underlying liver cirrhosis induced using carbon tetrachloride (CCl4). Male New Zealand white rabbits (n = 3) received CCl4 by intragastric administration once weekly. Concentrations started at 5% v/v CCl4 dissolved in olive oil. CCl4 dosing was progressively increased every week by 2.5% v/v increments for the duration of treatment (16 weeks total). VX2 tumors were then orthotopically implanted into the left hepatic lobe and allowed to grow for 3 weeks. Cross-sectional imaging confirmed the presence of hepatic tumors. Gross and histopathological evaluations showed reproducible tumor growth in the presence of liver cirrhosis in all animals.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Carbon Tetrachloride / adverse effects
  • Carcinoma, Hepatocellular* / pathology
  • Liver / pathology
  • Liver Cirrhosis
  • Liver Cirrhosis, Experimental* / chemically induced
  • Liver Cirrhosis, Experimental* / pathology
  • Liver Neoplasms* / pathology
  • Liver Neoplasms, Experimental* / pathology
  • Male
  • Rabbits

Substances

  • Carbon Tetrachloride